Trevi TherapeuticsTRVI
13F holders, Q1 2024 (March 31)80holders
3famous investors
$3.45avg. 13F price*
At the end of Q1 2024, 80 institutions reported holding Trevi Therapeutics Inc. (TRVI) in their 13F filings. The largest holders were NEA Management Company, LLC ($39.2M), Frazier Life Sciences Management, L.P. ($25.5M) and Rubric Capital Management LP ($19.2M). 3 famous investors held it, including Andreas Halvorsen (0.1% of Viking Global Investors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Trevi Therapeutics Inc.
- CUSIP
- 89532M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 22 | $15.2M |
| Exits | 5 | $1.2M |
Ownership 80 holders
| NEA Management Company, LLC | 2.44% | No change | 11,370,376 | $39.2M |
| Frazier Life Sciences Management, L.P. | 1.08% | No change | 7,381,090 | $25.5M |
| Rubric Capital Management LP | 0.57% | Reduce -2.1% | 5,564,123 | $19.2M |
| Viking Global Investors | 0.06% | No change | 4,400,000 | $15.2M |
| Venrock Adviser, LLC | 0.56% | Add +0.0% | 3,422,675 | $11.8M |
| Opaleye Management Inc. | 2.00% | Add +4.3% | 2,645,000 | $9.1M |
| BlackRock Inc. | 0.00% | Add +2.4% | 2,375,709 | $8.2M |
| Vanguard Group Inc. | 0.00% | Add +2.7% | 2,303,648 | $7.9M |
| Logos Global Management LP | 0.80% | New | 2,200,000 | $7.6M |
| MPM Bioimpact LLC | 0.74% | New | 1,340,960 | $4.6M |
| MAI Capital Management | 0.04% | Reduce -11.5% | 1,131,821 | $3.9M |
| Rosalind Advisors, Inc. | 2.99% | Reduce -50.3% | 926,016 | $3.2M |
| Geode Capital Management, LLC | 0.00% | Add +5.7% | 897,965 | $3.1M |
| Silverarc Capital Management, LLC | 0.82% | Reduce -2.3% | 844,235 | $2.9M |
| State Street Corp. | 0.00% | Add +7.7% | 798,249 | $2.8M |
| Landscape Capital Management, L.L.C. | 0.22% | Reduce -18.7% | 740,128 | $2.6M |
| Checkpoint Capital L.P. | 1.17% | Reduce -60.8% | 506,082 | $1.7M |
| Northern Trust Corp. | 0.00% | Add +4.3% | 327,692 | $1.1M |
| Propel Bio Management, LLC | 0.52% | New | 260,000 | $897K |
| Simplify Asset Management Inc. | 0.07% | New | 200,000 | $690K |
| J. Goldman & Co LP | 0.02% | No change | 137,873 | $476K |
| Bank of New York Mellon Corp | 0.00% | Reduce -3.6% | 128,627 | $444K |
| Renaissance Technologies | 0.00% | Reduce -78.5% | 116,842 | $403K |
| Shay Capital LLC | 0.12% | New | 113,662 | $392K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 107,707 | $372K |
| PFS Partners, LLC | 0.23% | No change | 99,000 | $342K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -54.4% | 96,481 | $333K |
| Nuveen Asset Management, LLC | 0.00% | No change | 74,849 | $258K |
| Morgan Stanley | 0.00% | Reduce -54.2% | 68,227 | $235K |
| WealthTrust Axiom LLC | 0.07% | No change | 63,500 | $219K |
| Oppenheimer & Co. Inc. | 0.00% | New | 60,415 | $208K |
| Rhumbline Advisers | 0.00% | Add +0.9% | 51,955 | $179K |
| American Century Companies Inc. | 0.00% | Add +119.4% | 46,206 | $159K |
| Atom Investors LP | 0.02% | Add +15.4% | 45,736 | $158K |
| UBS Group AG | 0.00% | Add +34.2% | 42,118 | $145K |
| Bailard, Inc. | 0.00% | New | 40,900 | $141K |
| Goldman Sachs Group Inc. | 0.00% | Add +58.8% | 37,974 | $131K |
| Tejara Capital Ltd | 0.05% | Reduce -97.0% | 37,481 | $129K |
| Trust Co. of Toledo NA | 0.02% | No change | 36,502 | $126K |
| LPL Financial LLC | 0.00% | New | 36,000 | $124K |
| Barclays PLC | 0.00% | Reduce -44.8% | 35,195 | $121K |
| Citadel Advisors | 0.00% | Reduce -84.5% | 28,680 | $99K |
| United Bank | 0.01% | No change | 28,450 | $98K |
| JPMorgan Chase & Co. | 0.00% | Reduce -5.6% | 25,463 | $88K |
| Dimensional Fund Advisors LP | 0.00% | New | 22,735 | $78K |
| MetLife Investment Management, LLC | 0.00% | New | 22,693 | $78K |
| Bank of America Corp. | 0.00% | Reduce -47.7% | 21,976 | $76K |
| Ameriprise Financial Inc. | 0.00% | New | 21,608 | $75K |
| American International Group, Inc. | 0.00% | Reduce -0.8% | 20,773 | $72K |
| BNP Paribas Financial Markets | 0.00% | Reduce -84.4% | 20,577 | $71K |
| Invesco Ltd. | 0.00% | No change | 19,888 | $69K |
| Jump Financial, LLC | 0.00% | New | 18,441 | $64K |
| Deutsche Bank AG | 0.00% | New | 17,817 | $61K |
| Jane Street Group, LLC | 0.00% | Reduce -74.1% | 17,094 | $59K |
| Wells Fargo & Company | 0.00% | Add +29.9% | 16,839 | $58K |
| New York State Common Retirement Fund | 0.00% | Reduce -59.0% | 15,058 | $52K |
| Squarepoint Ops LLC | 0.00% | Reduce -84.9% | 15,027 | $52K |
| SG Americas Securities, LLC | 0.00% | Reduce -85.2% | 14,592 | $50K |
| T. Rowe Price Associates Inc. | 0.00% | New | 13,561 | $47K |
| Voya Investment Management LLC | 0.00% | New | 13,274 | $46K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 13,074 | $45K |
| Stifel Financial Corp. | 0.00% | Add +0.0% | 10,103 | $35K |
| Raymond James & Associates | 0.00% | New | 10,000 | $35K |
| Citigroup Inc. | 0.00% | Add +25.1% | 8,703 | $30K |
| STRS Ohio | 0.00% | Reduce -5.8% | 8,200 | $28K |
| California State Teachers Retirement System | 0.00% | Reduce -38.9% | 4,237 | $15K |
| Legal & General Group Plc | 0.00% | No change | 3,974 | $14K |
| FMR LLC | 0.00% | Add +0.7% | 3,535 | $12K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 3,438 | $12K |
| Metropolitan Life Insurance Co | 0.00% | New | 2,335 | $8K |
| Lanark Financial, Inc. | 0.00% | No change | 2,000 | $6K |
| Amalgamated Bank | 0.00% | Reduce -61.4% | 1,403 | $5K |
| Royal Bank of Canada | 0.00% | Reduce -89.7% | 1,463 | $5K |
| Federated Hermes, Inc. | 0.00% | Reduce -18.6% | 773 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -91.9% | 610 | $2K |
| Farther Finance Advisors, LLC | 0.00% | New | 55 | $185 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 25 | $86 |
| Avior Wealth Management, LLC | 0.00% | New | 6 | $20 |
| Nisa Investment Advisors, LLC | 0.00% | New | 3 | $10 |
| Cwm, LLC | 0.00% | New | 3 | $0 |
"% of holder's portfolio" is TRVI's weight in each manager's 13F, not the share of Trevi Therapeutics Inc. the manager owns.